Collaborations

CSIR-NCL is a science and knowledge based research, development and consulting organization situated in Pune offering selected scientific services to industries like Contract Research, Consultancy and Technical Services. CSIR-NCL also undertakes short term R & D projects for emerging market needs.

The various investigational new drugs of RBPL were analysed to elucidate its physico-chemical properties like Surface morphology, particle size, charge, melting point, etc. and it reconfirmed the presence of nano structures in selected batches.

CMET is an institution under Department of Electronics & Information Technology, Ministry of Communications and Information Technology (MCIT), Government of India. CMET carries out research and development on electronic materials and their processing keeping in view the development in the electronics and IT industry all over the world.CMET provides sophisticated material characterization and testing services like Energy Dispersive X-Ray Spectroscopy (EDAX), Dynamic light scattering (DLS), zeta potential, Scanning Electron Microscope (SEM), X-ray powder diffraction (XRD),Transmission electron microscopy(TEM) etc. for the industry.

Many facets of Physical characterization were explored in CMET and application of nano materials in other fields like sensors / nano drug carrier in drug delivery, etc. are studied for potential use in these fields. Joint projects are also being submitted to the target funding agencies for further the work in nano applications.

NCCS is an autonomous organization aided by the Department of Biotechnology, Government of India. National Cell Repository and the preclinical studies are the core strength of NCCS. Further NCCS has been at the forefront of basic research in diverse fields of cell biology, especially those addressing paramount human health issues like cancer, metabolic and infectious diseases, and regenerative medicine.

The research at NCCS is focused on answering challenging questions through approaches that integrate modern and conventional disciplines, including computational and structural biology, genomics and proteomics, stem cell biology, immunology and microbiology.

The Investigational New drugs being developed in RBPL for treating various ailments including cancers undergo exhaustive battery of pre-clinical testing including cell line based in vitro work. Our company has been working closely with NCCS for sourcing cancer cell lines, using varied facilities and interacting with scientific community to explore mechanism of actions of the drugs. After completing the basal experimental work at RBPL, a more nuanced advanced studies were carried out using NCCS facilities.

SP College, Pune is a premier educational Institute in Pune established in 1916 as a New Poona College. It has an expertise and sophisticated infrastructure suitable for research activities in pre- clinical studies. S P College has developed experimental models (in vitro and in vivo) which are suitable for screening various drugs under investigation within a short span of time.

One of the scientifically accepted models for drug testing is Chick Embryo Yolk Sac Membrane (YSM). RBPL has utilized this model for many pipeline drugs for exploring their probable mechanism of action and to draw on this experience to design more critical in vivo experiments.

ACTREC is the state-of-the-art R&D satellite of the Tata Memorial Centre (TMC), which also includes under its umbrella the Tata Memorial Hospital (TMH) the largest cancer hospital in Asia. ACTREC has the mandate to function as a national centre for treatment, research and education in cancer. ACTREC comprises of 2 arms – one for basic research and another for clinical research. ACTREC has a 100-bed hospital fully equipped with state-of-the-art diagnostic and therapeutic facilities. Research investigations currently focus on molecular mechanisms responsible for causation of major human cancers relevant to India.

Our company has selected ACTREC as one of the clinical trial site for its candidate drugs on cancer and is also working on other research streams using in vitro / in vivo models for generating proof of concept for new drugs.

KLE’s Shri B M K Ayurveda Mahavidyalaya, Belgaum was established in the year 1933 with the objective of revitalizing the science of Ayurveda, its utilization by society, awareness of health importance and entrepreneurship in Ayurveda for youths. Further KLE Ayurved Multispecialty Hospital has NABH accreditation and KLE Shri B M K Ayurveda Mahavidyalaya has NAAC ‘A’ grade.

RBPL has initiated activities with KLE’s Shri B M K Ayurveda Mahavidyalaya such as Academic, Clinical and Clinical Research.

The details are as follows :

• Academic : A joint Rasayu Fellowship course in Ayurvedic Oncology for two years through our sister concern Rasayu Cancer Clinic, Pune.
• Clinical : OPD for treating cancer patients is established and it is catering needs of the Cancer patients in North Karnataka through sister concern Rasayu Cancer Clinic, Pune
• Clinical Research : An exploratory clinical trial of one of the pipeline drugs to evaluate efficacy in cancer patients is already underway. The outcome of the trial will lead to establish an affordable drug for the treatment of cancer patients.

MIT is renowned institute offering undergraduate and post graduate degree programs in Science, Engineering and Technology recognized affiliated with “Savitribai Phule Pune University” ( SPPU ) and approved by Pharmacy Council of India, All India Council for Technical Education (AICTE), UGC.

MIP, MIT has a facility for animal house wherein nano medicines can be tested before proceeding with clinical trials. Our team of scientists are exploring joint areas of work with focus areas such as designing new formula and products involving biotech/ biotech engineering, nanotech, agriculture biotech, phytochemical and conventional medicine standardization.